Non-clinical evidence supporting the upcoming CLD-201 clinical trial: Cell-based oncolytic virotherapy for multiple solid tumors. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
Imagine a forest fire. Flames jump from tree to tree, leaving destruction in their wake. Only the trees burn, but the fire wreaks havoc on the entire ecosystem. Birds have nowhere to build nests; the ...
NK cells have a crucial role in cancer surveillance and offer a potential avenue for adoptive cell transfer as either mono- or combination immunotherapy. Previous investigations into transferring ...
In humans, there are two types of FcγR: the activating receptor, which contains the CD64 (FcγRI), CD32a (FcγRIIA), CD32c (FcγRIIC), CD16a (FcγRIIIA), and CD16b (FcγRIIIB); and the inhibiting receptor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results